Company News
Tuesday, August 30, 2016
BRIEF-FDA accepts Mitsubishi Tanabe Pharma's NDA filing for Edaravone to treat ALS
* FDA accepts Mitsubishi Tanabe Pharma's NDA filing for
Edaravone to treat ALS
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment